| Line Item | 2022-01-31 | Y/Y |
|---|---|---|
| Revenue | $192.3M | +13.8% |
| Cost of Revenue | $73.9M | +15.1% |
| Gross Profit | $118.4M | +13.0% |
| R&D Expense | $38.2M | +5.9% |
| SG&A Expense | $23.5M | +14.4% |
| Operating Income | -$1.9M | +30.5% |
| Pre-tax Income | -$1.8M | +25.7% |
| Income Tax | $85K | +0.0% |
| Net Income | -$1.8M |
| Line Item | 2022-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $19.7M | +13.7% |
| Short-term Investments | $11.6M | +5.4% |
| Accounts Receivable | $7.3M | +39.8% |
| Inventory | $13.8M | +13.1% |
| Current Assets | $66.0M | +17.9% |
| Total Assets | $109.3M | +22.6% |
| Current Liabilities | $46.9M | +0.6% |
| Line Item | 2022-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $6.7M | +52.4% |
| Capital Expenditures | $4.2M | +33.0% |
| Investing Cash Flow | -$4.9M | -2234.1% |
| Financing Cash Flow | $601K | -41.2% |
| Free Cash Flow | $2.5M | +103.1% |
| +28.3% |
| Total Liabilities |
| $58.2M |
| +17.5% |
| Stockholders' Equity | $51.1M | +29.1% |